NCT00219310
- Conditions
- Communicable Diseases, DNA Virus Infections, Disease Attributes, +19 more
- Locations
-
- Novartis Pharmaceuticals East Hanover, New Jersey, United States
Clinical trial condition
Explore clinical trials studying Recurrent Genital Herpes (RGH). Study availability and eligibility vary by location and protocol.
NCT00219310